Analysts think CODX stock price could increase by 25%
Jun 14, 2024, 6:29 AM
-17.18%
What does CODX do
Co-Diagnostics, Inc., based in Salt Lake City, Utah, develops and sells molecular diagnostic tools and reagents for infectious diseases, cancer screening, and agriculture, and went public in 2017. The company also advances portable PCR devices for point-of-care use and designs tests for its Co-Dx PCR Home platform.
3 analysts think CODX stock price will increase by 25.15%. The current median analyst target is $2.04 compared to a current stock price of $1.63. The lowest analysts target is $2.02 and the highest analyst target is $2.10.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.